Article info

Download PDFPDF
Short report
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
  1. Correspondence to Dr Heli Nevanlinna, Helsinki University Central Hospital, Department of Obstetrics and Gynecology, Biomedicum Helsinki, PO Box 700, FIN-00029 HUS, Finland; heli.nevanlinna{at}hus.fi
View Full Text

Citation

Pelttari LM, Kiiski J, Nurminen R, et al
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer

Publication history

  • Received February 24, 2012
  • Revised April 27, 2012
  • Accepted May 2, 2012
  • First published May 31, 2012.
Online issue publication 
July 11, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.